株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓バイオマーカー検査の世界市場の分析

Global Cardiac Biomarkers Testing Market (2019-2025)

発行 KBV Research 商品コード 888281
出版日 ページ情報 英文 250 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
心臓バイオマーカー検査の世界市場の分析 Global Cardiac Biomarkers Testing Market (2019-2025)
出版日: 2019年06月30日 ページ情報: 英文 250 Pages
概要

当レポートでは、世界の心臓バイオマーカー検査市場について調査分析し、市場概要、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 市場範囲・手法

第2章 市場概要

  • イントロダクション
  • 市場に影響を与える主な要因

第3章 世界の心臓バイオマーカー検査市場:タイプ別

  • イントロダクション
    • クレアチンキナーゼ (CK-MB)
    • トロポニン
    • ミオグロビン
    • ナトリウム利尿ペプチド (BNP・NT-proBNP)
    • 虚血修飾アルブミン
    • その他

第4章 世界の心臓バイオマーカー検査市場:適応別

  • イントロダクション
    • 心筋梗塞 (MI)
    • 鬱血性心不全 (CHF)
    • 急性冠動脈症候群
    • アテローム性動脈硬化症
    • その他

第5章 世界の心臓バイオマーカー検査市場:検査場所別

  • イントロダクション
    • POC
    • 臨床検査

第6章 世界の心臓バイオマーカー検査市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ

第7章 企業プロファイル

  • Trivitron Healthcare Pvt. Ltd.
  • ABBOTT Laboratories
  • Siemens AG (Siemens Healthineers, Inc.)
  • Becton, Dickinson and Company
  • Bio-Rad laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation (Beckman Coulter, Inc.)
  • Thermo Fischer Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
図表

LIST OF TABLES

  • TABLE 1: GLOBAL CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 2: GLOBAL CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 3: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 4: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 5: GLOBAL CREATINE KINASE (CK-MB) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6: GLOBAL CREATINE KINASE (CK-MB) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7: GLOBAL TROPONINS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8: GLOBAL TROPONINS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9: GLOBAL MYOGLOBIN MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 10: GLOBAL MYOGLOBIN MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 11: GLOBAL NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12: GLOBAL NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13: GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 14: GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 15: GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 16: GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 17: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 18: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 19: GLOBAL MYOCARDIAL INFARCTION MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20: GLOBAL MYOCARDIAL INFARCTION MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21: GLOBAL CONGESTIVE HEART FAILURE MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22: GLOBAL CONGESTIVE HEART FAILURE MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23: GLOBAL ACUTE CORONARY SYNDROME MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 24: GLOBAL ACUTE CORONARY SYNDROME MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 25: GLOBAL ATHEROSCLEROSIS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26: GLOBAL ATHEROSCLEROSIS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27: GLOBAL OTHERS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 28: GLOBAL OTHERS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 29: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 30: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 31: GLOBAL POINT OF CARE TESTING MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32: GLOBAL POINT OF CARE TESTING MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33: GLOBAL LABORATORY TESTING MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 34: GLOBAL LABORATORY TESTING MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 35: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 36: GLOBAL CARDIAC BIOMARKERS TESTING MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 37: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 38: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 39: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 40: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 41: NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 42: NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 43: NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 44: NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 45: NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 46: NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 47: NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 48: NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 49: NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 50: NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 51: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 52: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 53: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 54: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 55: NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 56: NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 57: NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 58: NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 59: NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 60: NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 61: NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 62: NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 63: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 64: NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 65: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 66: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 67: NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 68: NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 69: NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 70: NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 71: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 72: NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 73: USA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 74: USA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 75: USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 76: USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 77: USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 78: USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 79: USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 80: USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 81: CANADA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 82: CANADA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 83: CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 84: CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 85: CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 86: CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 87: CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 88: CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 89: MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 90: MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 91: MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 92: MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 93: MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 94: MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 95: MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 96: MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 97: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 98: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 99: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 100: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 101: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 102: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 103: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 104: REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 105: EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 106: EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 107: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 108: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 109: EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 110: EUROPE CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 111: EUROPE TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 112: EUROPE TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 113: EUROPE MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 114: EUROPE MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 115: EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 116: EUROPE NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 117: EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 118: EUROPE ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 119: EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 120: EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 121: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 122: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 123: EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 124: EUROPE MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 125: EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 126: EUROPE CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 127: EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 128: EUROPE ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 129: EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 130: EUROPE ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 131: EUROPE OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 132: EUROPE OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 133: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 134: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 135: EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 136: EUROPE POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 137: EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 138: EUROPE LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 139: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 140: EUROPE CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 141: GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 142: GERMANY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 143: GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 144: GERMANY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 145: GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 146: GERMANY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 147: GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 148: GERMANY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 149: UK CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 150: UK CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 151: UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 152: UK CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 153: UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 154: UK CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 155: UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 156: UK CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 157: FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 158: FRANCE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 159: FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 160: FRANCE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 161: FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 162: FRANCE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 163: FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 164: FRANCE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 165: RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 166: RUSSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 167: RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 168: RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 169: RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 170: RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 171: RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 172: RUSSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 173: SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 174: SPAIN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 175: SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 176: SPAIN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 177: SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 178: SPAIN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 179: SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 180: SPAIN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 181: ITALY CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 182: ITALY CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 183: ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 184: ITALY CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 185: ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 186: ITALY CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 187: ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 188: ITALY CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 189: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 190: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 191: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 192: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 193: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 194: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 195: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 196: REST OF EUROPE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 197: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 198: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 199: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 200: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 201: ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 202: ASIA PACIFIC CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 203: ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 204: ASIA PACIFIC TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 205: ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 206: ASIA PACIFIC MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 207: ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 208: ASIA PACIFIC NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 209: ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 210: ASIA PACIFIC ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 211: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 212: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 213: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 214: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 215: ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 216: ASIA PACIFIC MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 217: ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 218: ASIA PACIFIC CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 219: ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 220: ASIA PACIFIC ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 221: ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 222: ASIA PACIFIC ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 223: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 224: ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 225: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 226: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 227: ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 228: ASIA PACIFIC POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 229: ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 230: ASIA PACIFIC LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 231: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 232: ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 233: CHINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 234: CHINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 235: CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 236: CHINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 237: CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 238: CHINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 239: CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 240: CHINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 241: JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 242: JAPAN CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 243: JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 244: JAPAN CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 245: JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 246: JAPAN CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 247: JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 248: JAPAN CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 249: INDIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 250: INDIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 251: INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 252: INDIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 253: INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 254: INDIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 255: INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 256: INDIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 257: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 258: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 259: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 260: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 261: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 262: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 263: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 264: SOUTH KOREA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 265: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 266: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 267: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 268: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 269: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 270: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 271: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 272: SINGAPORE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 273: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 274: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 275: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 276: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 277: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 278: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 279: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 280: MALAYSIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 281: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 282: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 283: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 284: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 285: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 286: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 287: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 288: REST OF ASIA PACIFIC CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 289: LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 290: LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 291: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 292: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 293: LAMEA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 294: LAMEA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 295: LAMEA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 296: LAMEA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 297: LAMEA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 298: LAMEA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 299: LAMEA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 300: LAMEA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 301: LAMEA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 302: LAMEA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 303: LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 304: LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 305: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 306: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 307: LAMEA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 308: LAMEA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 309: LAMEA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 310: LAMEA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 311: LAMEA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 312: LAMEA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 313: LAMEA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 314: LAMEA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 315: LAMEA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 316: LAMEA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 317: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 318: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 319: LAMEA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 320: LAMEA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 321: LAMEA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 322: LAMEA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 323: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 324: LAMEA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 325: BRAZIL CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 326: BRAZIL CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 327: BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 328: BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 329: BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 330: BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 331: BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 332: BRAZIL CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 333: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 334: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 335: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 336: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 337: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 338: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 339: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 340: ARGENTINA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 341: UAE CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 342: UAE CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 343: UAE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 344: UAE CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 345: UAE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 346: UAE CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 347: UAE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 348: UAE CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 349: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 350: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 351: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 352: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 353: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 354: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 355: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 356: SAUDI ARABIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 357: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 358: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 359: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 360: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 361: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 362: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 363: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 364: SOUTH AFRICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 365: NIGERIA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 366: NIGERIA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 367: NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 368: NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 369: NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 370: NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 371: NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 372: NIGERIA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 373: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
  • TABLE 374: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
  • TABLE 375: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
  • TABLE 376: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
  • TABLE 377: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
  • TABLE 378: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
  • TABLE 379: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
  • TABLE 380: REST OF LAMEA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
  • TABLE 381: KEY INFORMATION - TRIVITRON HEALTHCARE PVT. LTD.
  • TABLE 382: KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 383: KEY INFORMATION - SIEMENS AG
  • TABLE 384: KEY INFORMATION - BECTON, DICKINSON AND COMPANY
  • TABLE 385: KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 386: KEY INFORMATION - RANDOX LABORATORIES LIMITED
  • TABLE 387: KEY INFORMATION - DANAHER CORPORATION
  • TABLE 388: KEY INFORMATION - THERMO FISHER SCIENTIFIC, INC.
  • TABLE 389: KEY INFORMATION -JOHNSON AND JOHNSON
  • TABLE 390: KEY INFORMATION - QUIDEL CORPORATION

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH
  • FIG 2: RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
  • FIG 3: SWOT ANALYSIS: ABBOTT LABORATORIES
  • FIG 4: SWOT ANALYSIS: SIEMENS AG
  • FIG 5: SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
  • FIG 6: SWOT ANALYSIS: DANAHER CORPORATION
  • FIG 7: SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
  • FIG 8: SWOT ANALYSIS: JOHNSON & JOHNSON
目次

The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period.

Cardiac biomarkers or cardiac markers are endogenous substances which are released in the blood stream when the heart is damaged or stressed. The acute coronary syndrome is caused by a plaque formed due to atherosclerosis, which causes thrombus formation in the damaged coronary artery and results in a sudden decrease in the amount of blood and oxygen which reaches the heart. Angina is due to the reduced blood supply in the heart, and when such blood flow is interrupted for 30-60 min, it can cause necrosis of heart muscle, resulting in myocardial infarction.

The recent product launches and further developments in the products are major growth trends which are providing lucrative growth opportunities to the cardiac biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key contributing factor to sector growth. Alere triage panel, manufactured by Alere, Inc., is a combination of three major biomarkers namely, CK-MB, myoglobin, and troponin I. The test is handy due to efficient detection of the cardiovascular disease and, being a combination product, there is a great demand for the test in the market.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. The PoC testing segment is projected to witness growth at the highest CAGR during the forecast period. The rising demand for the PoC segment has led to the growth of the segment. Moreover, the rising awareness in the developing countries regarding the use of PoC testing and its application in cardiac biomarkers has nurtured the market growth. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Study

Market Segmentation:

By Type

  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others

By Application

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

By Location of Testing

  • Point of Care Testing
  • Laboratory Testing

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cardiac Biomarkers Testing Market, by Type
    • 1.4.2 Global Cardiac Biomarkers Testing Market, by Application
    • 1.4.3 Global Cardiac Biomarkers Testing Market, by Location of Testing
    • 1.4.4 Global Cardiac Biomarkers Testing Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Executive Summary
    • 2.1.3 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraint

Chapter 3. Global Cardiac Biomarkers Testing Market by Type

    • 3.1.1 Global Creatine Kinase (CK-MB) Market by Region
    • 3.1.2 Global Troponins Market by Region
    • 3.1.3 Global Myoglobin Market by Region
    • 3.1.4 Global Natriuretic Peptides (BNP and NT-proBNP) Market by Region
    • 3.1.5 Global Ischemia Modified Albumin Market by Region
    • 3.1.6 Global Others Market by Region

Chapter 4. Global Cardiac Biomarkers Testing Market by Application

    • 4.1.1 Global Myocardial Infarction Market by Region
    • 4.1.2 Global Congestive Heart Failure Market by Region
    • 4.1.3 Global Acute Coronary Syndrome Market by Region
    • 4.1.4 Global Atherosclerosis Market by Region
    • 4.1.5 Global Others Market by Region

Chapter 5. Global Cardiac Biomarkers Testing Market by Location of Testing

    • 5.1.1 Global Point of Care Testing Market by Region
    • 5.1.2 Global Laboratory Testing Market by Region

Chapter 6. Global Cardiac Biomarkers Testing Market by Region

  • 6.1 North America Cardiac Biomarkers Testing Market
    • 6.1.1 North America Cardiac Biomarkers Testing Market by Type
      • 6.1.1.1 North America Creatine Kinase (CK-MB) Market by Country
      • 6.1.1.2 North America Troponins Market by Country
      • 6.1.1.3 North America Myoglobin Market by Country
      • 6.1.1.4 North America Natriuretic Peptides (BNP and NT-proBNP) Market by Country
      • 6.1.1.5 North America Ischemia Modified Albumin Market by Country
      • 6.1.1.6 North America Others Market by Country
    • 6.1.2 North America Cardiac Biomarkers Testing Market by Application
      • 6.1.2.1 North America Myocardial Infarction Market by Country
      • 6.1.2.2 North America Congestive Heart Failure Market by Country
      • 6.1.2.3 North America Acute Coronary Syndrome Market by Country
      • 6.1.2.4 North America Atherosclerosis Market by Country
      • 6.1.2.5 North America Others Market by Country
    • 6.1.3 North America Cardiac Biomarkers Testing Market by Location of Testing
      • 6.1.3.1 North America Point of Care Testing Market by Country
      • 6.1.3.2 North America Laboratory Testing Market by Country
    • 6.1.4 North America Cardiac Biomarkers Testing Market by Country
      • 6.1.4.1 USA Cardiac Biomarkers Testing Market
        • 6.1.4.1.1 USA Cardiac Biomarkers Testing Market by Type
        • 6.1.4.1.2 USA Cardiac Biomarkers Testing Market by Application
        • 6.1.4.1.3 USA Cardiac Biomarkers Testing Market by Location of Testing
      • 6.1.4.2 Canada Cardiac Biomarkers Testing Market
        • 6.1.4.2.1 Canada Cardiac Biomarkers Testing Market by Type
        • 6.1.4.2.2 Canada Cardiac Biomarkers Testing Market by Application
        • 6.1.4.2.3 Canada Cardiac Biomarkers Testing Market by Location of Testing
      • 6.1.4.3 Mexico Cardiac Biomarkers Testing Market
        • 6.1.4.3.1 Mexico Cardiac Biomarkers Testing Market by Type
        • 6.1.4.3.2 Mexico Cardiac Biomarkers Testing Market by Application
        • 6.1.4.3.3 Mexico Cardiac Biomarkers Testing Market by Location of Testing
      • 6.1.4.4 Rest of North America Cardiac Biomarkers Testing Market
        • 6.1.4.4.1 Rest of North America Cardiac Biomarkers Testing Market by Type
        • 6.1.4.4.2 Rest of North America Cardiac Biomarkers Testing Market by Application
        • 6.1.4.4.3 Rest of North America Cardiac Biomarkers Testing Market by Location of Testing
  • 6.2 Europe Cardiac Biomarkers Testing Market
    • 6.2.1 Europe Cardiac Biomarkers Testing Market by Type
      • 6.2.1.1 Europe Creatine Kinase (CK-MB) Market by Country
      • 6.2.1.2 Europe Troponins Market by Country
      • 6.2.1.3 Europe Myoglobin Market by Country
      • 6.2.1.4 Europe Natriuretic Peptides (BNP and NT-proBNP) Market by Country
      • 6.2.1.5 Europe Ischemia Modified Albumin Market by Country
      • 6.2.1.6 Europe Others Market by Country
    • 6.2.2 Europe Cardiac Biomarkers Testing Market by Application
      • 6.2.2.1 Europe Myocardial Infarction Market by Country
      • 6.2.2.2 Europe Congestive Heart Failure Market by Country
      • 6.2.2.3 Europe Acute Coronary Syndrome Market by Country
      • 6.2.2.4 Europe Atherosclerosis Market by Country
      • 6.2.2.5 Europe Others Market by Country
    • 6.2.3 Europe Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.3.1 Europe Point of Care Testing Market by Country
      • 6.2.3.2 Europe Laboratory Testing Market by Country
    • 6.2.4 Europe Cardiac Biomarkers Testing Market by Country
      • 6.2.4.1 Germany Cardiac Biomarkers Testing Market
        • 6.2.4.1.1 Germany Cardiac Biomarkers Testing Market by Type
        • 6.2.4.1.2 Germany Cardiac Biomarkers Testing Market by Application
        • 6.2.4.1.3 Germany Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.4.2 UK Cardiac Biomarkers Testing Market
        • 6.2.4.2.1 UK Cardiac Biomarkers Testing Market by Type
        • 6.2.4.2.2 UK Cardiac Biomarkers Testing Market by Application
        • 6.2.4.2.3 UK Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.4.3 France Cardiac Biomarkers Testing Market
        • 6.2.4.3.1 France Cardiac Biomarkers Testing Market by Type
        • 6.2.4.3.2 France Cardiac Biomarkers Testing Market by Application
        • 6.2.4.3.3 France Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.4.4 Russia Cardiac Biomarkers Testing Market
        • 6.2.4.4.1 Russia Cardiac Biomarkers Testing Market by Type
        • 6.2.4.4.2 Russia Cardiac Biomarkers Testing Market by Application
        • 6.2.4.4.3 Russia Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.4.5 Spain Cardiac Biomarkers Testing Market
        • 6.2.4.5.1 Spain Cardiac Biomarkers Testing Market by Type
        • 6.2.4.5.2 Spain Cardiac Biomarkers Testing Market by Application
        • 6.2.4.5.3 Spain Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.4.6 Italy Cardiac Biomarkers Testing Market
        • 6.2.4.6.1 Italy Cardiac Biomarkers Testing Market by Type
        • 6.2.4.6.2 Italy Cardiac Biomarkers Testing Market by Application
        • 6.2.4.6.3 Italy Cardiac Biomarkers Testing Market by Location of Testing
      • 6.2.4.7 Rest of Europe Cardiac Biomarkers Testing Market
        • 6.2.4.7.1 Rest of Europe Cardiac Biomarkers Testing Market by Type
        • 6.2.4.7.2 Rest of Europe Cardiac Biomarkers Testing Market by Application
        • 6.2.4.7.3 Rest of Europe Cardiac Biomarkers Testing Market by Location of Testing
  • 6.3 Asia Pacific Cardiac Biomarkers Testing Market
    • 6.3.1 Asia Pacific Cardiac Biomarkers Testing Market by Type
      • 6.3.1.1 Asia Pacific Creatine Kinase (CK-MB) Market by Country
      • 6.3.1.2 Asia Pacific Troponins Market by Country
      • 6.3.1.3 Asia Pacific Myoglobin Market by Country
      • 6.3.1.4 Asia Pacific Natriuretic Peptides (BNP and NT-proBNP) Market by Country
      • 6.3.1.5 Asia Pacific Ischemia Modified Albumin Market by Country
      • 6.3.1.6 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Cardiac Biomarkers Testing Market by Application
      • 6.3.2.1 Asia Pacific Myocardial Infarction Market by Country
      • 6.3.2.2 Asia Pacific Congestive Heart Failure Market by Country
      • 6.3.2.3 Asia Pacific Acute Coronary Syndrome Market by Country
      • 6.3.2.4 Asia Pacific Atherosclerosis Market by Country
      • 6.3.2.5 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.3.1 Asia Pacific Point of Care Testing Market by Country
      • 6.3.3.2 Asia Pacific Laboratory Testing Market by Country
    • 6.3.4 Asia Pacific Cardiac Biomarkers Testing Market by Country
      • 6.3.4.1 China Cardiac Biomarkers Testing Market
        • 6.3.4.1.1 China Cardiac Biomarkers Testing Market by Type
        • 6.3.4.1.2 China Cardiac Biomarkers Testing Market by Application
        • 6.3.4.1.3 China Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.4.2 Japan Cardiac Biomarkers Testing Market
        • 6.3.4.2.1 Japan Cardiac Biomarkers Testing Market by Type
        • 6.3.4.2.2 Japan Cardiac Biomarkers Testing Market by Application
        • 6.3.4.2.3 Japan Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.4.3 India Cardiac Biomarkers Testing Market
        • 6.3.4.3.1 India Cardiac Biomarkers Testing Market by Type
        • 6.3.4.3.2 India Cardiac Biomarkers Testing Market by Application
        • 6.3.4.3.3 India Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.4.4 South Korea Cardiac Biomarkers Testing Market
        • 6.3.4.4.1 South Korea Cardiac Biomarkers Testing Market by Type
        • 6.3.4.4.2 South Korea Cardiac Biomarkers Testing Market by Application
        • 6.3.4.4.3 South Korea Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.4.5 Singapore Cardiac Biomarkers Testing Market
        • 6.3.4.5.1 Singapore Cardiac Biomarkers Testing Market by Type
        • 6.3.4.5.2 Singapore Cardiac Biomarkers Testing Market by Application
        • 6.3.4.5.3 Singapore Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.4.6 Malaysia Cardiac Biomarkers Testing Market
        • 6.3.4.6.1 Malaysia Cardiac Biomarkers Testing Market by Type
        • 6.3.4.6.2 Malaysia Cardiac Biomarkers Testing Market by Application
        • 6.3.4.6.3 Malaysia Cardiac Biomarkers Testing Market by Location of Testing
      • 6.3.4.7 Rest of Asia Pacific Cardiac Biomarkers Testing Market
        • 6.3.4.7.1 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Type
        • 6.3.4.7.2 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Application
        • 6.3.4.7.3 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
  • 6.4 LAMEA Cardiac Biomarkers Testing Market
    • 6.4.1 LAMEA Cardiac Biomarkers Testing Market by Type
      • 6.4.1.1 LAMEA Creatine Kinase (CK-MB) Market by Country
      • 6.4.1.2 LAMEA Troponins Market by Country
      • 6.4.1.3 LAMEA Myoglobin Market by Country
      • 6.4.1.4 LAMEA Natriuretic Peptides (BNP and NT-proBNP) Market by Country
      • 6.4.1.5 LAMEA Ischemia Modified Albumin Market by Country
      • 6.4.1.6 LAMEA Others Market by Country
    • 6.4.2 LAMEA Cardiac Biomarkers Testing Market by Application
      • 6.4.2.1 LAMEA Myocardial Infarction Market by Country
      • 6.4.2.2 LAMEA Congestive Heart Failure Market by Country
      • 6.4.2.3 LAMEA Acute Coronary Syndrome Market by Country
      • 6.4.2.4 LAMEA Atherosclerosis Market by Country
      • 6.4.2.5 LAMEA Others Market by Country
    • 6.4.3 LAMEA Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.3.1 LAMEA Point of Care Testing Market by Country
      • 6.4.3.2 LAMEA Laboratory Testing Market by Country
    • 6.4.4 LAMEA Cardiac Biomarkers Testing Market by Country
      • 6.4.4.1 Brazil Cardiac Biomarkers Testing Market
        • 6.4.4.1.1 Brazil Cardiac Biomarkers Testing Market by Type
        • 6.4.4.1.2 Brazil Cardiac Biomarkers Testing Market by Application
        • 6.4.4.1.3 Brazil Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.4.2 Argentina Cardiac Biomarkers Testing Market
        • 6.4.4.2.1 Argentina Cardiac Biomarkers Testing Market by Type
        • 6.4.4.2.2 Argentina Cardiac Biomarkers Testing Market by Application
        • 6.4.4.2.3 Argentina Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.4.3 UAE Cardiac Biomarkers Testing Market
        • 6.4.4.3.1 UAE Cardiac Biomarkers Testing Market by Type
        • 6.4.4.3.2 UAE Cardiac Biomarkers Testing Market by Application
        • 6.4.4.3.3 UAE Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.4.4 Saudi Arabia Cardiac Biomarkers Testing Market
        • 6.4.4.4.1 Saudi Arabia Cardiac Biomarkers Testing Market by Type
        • 6.4.4.4.2 Saudi Arabia Cardiac Biomarkers Testing Market by Application
        • 6.4.4.4.3 Saudi Arabia Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.4.5 South Africa Cardiac Biomarkers Testing Market
        • 6.4.4.5.1 South Africa Cardiac Biomarkers Testing Market by Type
        • 6.4.4.5.2 South Africa Cardiac Biomarkers Testing Market by Application
        • 6.4.4.5.3 South Africa Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.4.6 Nigeria Cardiac Biomarkers Testing Market
        • 6.4.4.6.1 Nigeria Cardiac Biomarkers Testing Market by Type
        • 6.4.4.6.2 Nigeria Cardiac Biomarkers Testing Market by Application
        • 6.4.4.6.3 Nigeria Cardiac Biomarkers Testing Market by Location of Testing
      • 6.4.4.7 Rest of LAMEA Cardiac Biomarkers Testing Market
        • 6.4.4.7.1 Rest of LAMEA Cardiac Biomarkers Testing Market by Type
        • 6.4.4.7.2 Rest of LAMEA Cardiac Biomarkers Testing Market by Application
        • 6.4.4.7.3 Rest of LAMEA Cardiac Biomarkers Testing Market by Location of Testing

Chapter 7. Company Profiles

  • 7.1 Trivitron Healthcare Pvt. Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 Recent strategies and developments:
      • 7.1.2.1 Collaborations, partnerships and agreements:
      • 7.1.2.2 Expansion:
  • 7.2 ABBOTT Laboratories
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.1 Recent strategies and developments:
      • 7.2.1.1 Acquisition and mergers:
      • 7.2.1.2 Product launches:
      • 7.2.1.3 Approvals:
    • 7.2.2 SWOT Analysis
  • 7.3 Siemens AG (Siemens Healthineers, Inc.)
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Collaborations, partnerships and agreements:
      • 7.3.5.2 Product launches:
    • 7.3.6 SWOT Analysis
  • 7.4 Becton, Dickinson and Company
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 SWOT Analysis
  • 7.5 Bio-Rad laboratories, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expenses
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Acquisition and mergers:
  • 7.6 Randox Laboratories Limited
    • 7.6.1 Company Overview
    • 7.6.2 Recent strategies and developments:
      • 7.6.2.1 Collaborations, partnerships and agreements:
  • 7.7 Danaher Corporation (Beckman Coulter, Inc.)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Collaborations, partnerships and agreements:
      • 7.7.5.2 Approvals:
    • 7.7.6 SWOT Analysis
  • 7.8 Thermo Fischer Scientific, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Acquisition and mergers:
    • 7.8.6 SWOT Analysis
  • 7.9 Johnson and Johnson
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental &Regional Analysis
    • 7.9.4 Research & Development Expenses
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Collaborations, partnerships and agreements:
      • 7.9.5.2 Acquisition and mergers:
    • 7.9.6 SWOT Analysis
  • 7.1 Quidel Corporation
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Regional Analysis
    • 7.10.4 Research & Development Expenses
Back to Top